Blood Immune Cell Biomarkers in Lung Cancer Patients Undergoing Treatment with a Combination of Chemotherapy and Immune Checkpoint Blockade.

Möller, Miriam; Turzer, Steffi; Ganchev, Georgi; Wienke, Andreas; Schütte, Wolfgang; Seliger, Barbara; Riemann, Dagmar

Möller, Miriam; Turzer, Steffi; Ganchev, Georgi; Wienke, Andreas; Schütte, Wolfgang; Seliger, Barbara; Riemann, Dagmar.

Afiliação

Möller M; Clinic of Internal Medicine, Hospital Martha-Maria Halle-Dölau, D-06120 Halle, Germany.
Turzer S; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, D-06112 Halle, Germany.
Ganchev G; Clinic of Internal Medicine, Hospital Martha-Maria Halle-Dölau, D-06120 Halle, Germany.
Wienke A; Institute of Medical Epidemiology, Biostatistics, and Informatics, Martin Luther University Halle-Wittenberg, D-06112 Halle, Germany.
Schütte W; Clinic of Internal Medicine, Hospital Martha-Maria Halle-Dölau, D-06120 Halle, Germany.
Seliger B; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, D-06112 Halle, Germany.
Riemann D; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, D-06112 Halle, Germany.

Cancers (Basel) ; 14(15)2022 Jul 28.

Article em En | MEDLINE | ID: mdl-35954354

Palavras-chave

biomarker; dendritic cells; immune checkpoint blockade; immune monitoring; lung cancer; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google